COA Available
Research In Stock Research Use Only
Cartalax
20mg · Lyophilized Powder · Purity ≥99%
Cartalax (Ala-Glu-Asp-Leu) is a synthetic tetrapeptide bioregulator from the Khavinson group, designed to target cartilage tissue, and used as a research tool in cartilage biology, chondrocyte function, and extracellular matrix gene expression research in preclinical models.
$159.99 CAD
Purchase Options
Subscriptions can be managed from your customer account. Prices in CAD.
Research Overview
Cartalax is a synthetic tetrapeptide bioregulator with the sequence Ala-Glu-Asp-Leu, developed by the Khavinson group at the St. Petersburg Institute of Bioregulation and Gerontology as a tissue-targeted peptide designed to modulate gene expression in cartilage. Preclinical research has studied Cartalax as a research tool in cartilage biology, examining effects on chondrocyte function, extracellular matrix component regulation, and connective tissue gene expression in cell and animal-based models. BME Health supplies Cartalax as a lyophilized high-purity research peptide. Supplied exclusively for laboratory and research use.
Preclinical studies have examined Cartalax within the framework of Khavinson short peptide bioregulator research, investigating its tissue-targeted effects on chondrocyte cell biology, extracellular matrix protein expression, and cartilage-associated gene regulation in cell and animal models. As a tetrapeptide bioregulator, Cartalax belongs to a class of short peptides proposed to interact with gene promoter regions in a tissue-selective manner — an area of ongoing investigation in the peptide bioregulator field. It provides a research tool for musculoskeletal and connective tissue biology investigations. All outcomes referenced do not constitute evidence of clinical efficacy or safety in humans.
Specifications
| Compound | Cartalax |
| Format | Lyophilized Powder |
| Size | 20mg |
| Purity (HPLC) | ≥99% |
| Item # | BME-CARTAL-A |
| Storage | −20°C, dry, dark |
| Price (CAD) | $159.99 |
COA / Testing
Batch documentation and third-party testing information are available for batch BME-CARTAL-A. COA previews appear only when documentation exists for the active batch.
Storage & Handling
Store lyophilized Cartalax at −20°C in a sealed, dry container protected from light. Avoid repeated freeze-thaw cycles after reconstitution. Prepare working solutions in appropriate research-grade buffer as required for each experimental session.
Shipping & Returns
Orders are processed on business days. Packaging is selected to maintain compound integrity in transit. Shipping timelines and return conditions are outlined in full in the Shipping & Returns policy — review before checkout if you have specific requirements. For orders with time-sensitive research schedules, contact support before placing your order.
Research Use Disclaimer
This product is supplied strictly for in-vitro and laboratory research use. It is not a drug, food supplement, or cosmetic and is not approved for human or veterinary clinical applications, diagnostics, or therapeutic use. Researchers are responsible for compliance with all applicable institutional and regulatory requirements in their jurisdiction.
Preparation Reference Guide
Research Solution Reference Calculator
Pre-filled with 20mg. Enter your solvent volume and target amount to see concentration and units on a U-100 syringe scale.
Concentration—
Volume to draw—
Syringe units (U-100)—
Per insulin unit—
For research-use calculations only. Always verify measurements independently — not medical guidance.
Questions before you order?
Browse the FAQ for documentation, storage, and sourcing answers, or contact our support team directly. We aim to respond to all research procurement inquiries within one business day.
Related
